Equities

KORU Medical Systems Inc

KRMD:NAQ

KORU Medical Systems Inc

Actions
  • Price (USD)2.57
  • Today's Change-0.10 / -3.75%
  • Shares traded36.47k
  • 1 Year change-9.19%
  • Beta0.4127
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year KORU Medical Systems Inc's net income fell 58.65% from a loss of 8.66m to a larger loss of 13.74m despite relatively flat revenues.
Gross margin62.49%
Net profit margin-38.16%
Operating margin-23.18%
Return on assets-37.15%
Return on equity-50.25%
Return on investment-43.48%
More ▼

Cash flow in USDView more

In 2023, cash reserves at KORU Medical Systems Inc fell by 5.93m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 4.89m for operations while cash used for investing totalled 814.60k.
Cash flow per share-0.2377
Price/Cash flow per share--
Book value per share0.4082
Tangible book value per share0.392
More ▼

Balance sheet in USDView more

KORU Medical Systems Inc has little financial risk as the capital structure does not rely on leverage.
Current ratio3.77
Quick ratio3.27
Total debt/total equity0.0199
Total debt/total capital0.0195
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -56.57%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-44.20
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.